Canada’s ‘Uber for Doctors’ Targets Long Medical Wait Times
(Bloomberg) -- Canada's taxpayer-funded health-care system has many benefits, but painfully long wait times to see a doctor isn't one of them. This is where innovators like Felix Health Inc. see the most potential for disruption.
The seven-months old firm offers the first “asynchronous” health-care service in the country, where a patient and a doctor don't need to meet in person to discuss a diagnosis.
Instead, a patient creates an account with Felix and fills out a 15-minute questionnaire. A doctor in Felix's network reviews it and makes a decision on whether to fill out a prescription, which is sent to a pharmacy for pick-up or for shipment within 48 hours.
“It is a great experience where the patient is only dealing with one service provider the whole way through and it creates a level of care that is extremely consistent, predictable and safe,” Kyle Zien, Felix's co-founder and chief executive officer, said in an interview.
Felix is the latest among a slew of startups looking to shake-up a single-payer system that some U.S. Democratic presidential candidates including Bernie Sanders are seeking to emulate. Many are taking a direct-to-consumer approach to health care to eliminate cumbersome wait times or offer medical support in remote areas with few doctors.
Some have received funding, with Felix raising C$750,000. Montreal-based Dialogue Technologies Inc. received C$40 million ($30 million) last month in a funding round led by Canadian pension fund Caisse de dépôt et placement du Québec, along with Munich-based Holtzbrinck Ventures.
Maple Corp., often considered the pioneer in the recent wave of telemedicine startups in Canada, raised C$4 million in March 2018 from a group of investors including MaRS, a Toronto-based innovation hub.
Long Wait Times
In a 2017 study by the Commonwealth Fund, a U.S. foundation focused on health-care research, Canada ranked the worst among 11 high-income countries on doctors' same-day responses to patient questions, wait times for emergency room care, specialists and elective surgery.
Focused only on lifestyle issues such as acne, hair loss, birth control and erectile dysfunction, Felix is like the “Uber for doctors,” where the next available physician can issue a prescription, Zien says. The company plans to add more treatments such as HIV prevention, smoking cessation, and wrinkles -- ailments where an in-person physical appointment isn't necessary.
Felix's focus on lifestyle disorders also builds on the idea that Canada's health-care system prioritizes the sick, and often overlooks less critical needs. It's the same model used by a number of U.S. upstarts selling sexual wellness drugs and baldness treatments such as Hims Inc. and Roman Health Medical LLC.
In addition to convenience, the startups offer privacy and discretion to patients who may feel embarrassed discussing these issues in person.
Service Costs
All this convenience comes at a cost. Felix charges patients for a doctor's consultation, typically about C$40, plus the cost of prescribed medication. Most provincial insurance plans in Canada only cover in-person doctor visits, so patients using virtual care must pay or seek coverage from their private or employer insurance plans.
For some patients, it's worth the money.
“When you look at the value of my time, I would pay C$50 each time if the value of the service is good,” says Gina Giouroukos, a retired police officer who recently used Maple to consult a doctor for fever and strep throat.
For the doctors, these services create a new conundrum: While many would like the freedom and flexibility that telemedicine offers, they worry about the safety and efficacy of a diagnosis without meeting a patient.
“Most doctors have significant hesitation about telemedicine and are concerned it is unsafe for patients, and that there is no continuity of care,” said Kelly Anderson, medical director at Felix.
Telemedicine is Coming
She adds that most of these concerns arise from lack of experience with telemedicine platforms. Many doctors in the country have been slow to adopt technological changes even as they're overworked and see up to 50 patients a day. Canada's lower adoption of medical technologies makes it one of the most expensive universal health-care systems among developed economies, research by the Fraser Institute shows.
“We're going to see telemedicine coming in Canada, whether physicians like it or not,” Anderson said. “It's better for physicians to be involved in shaping the safety practices and making these telemedicine avenues the best that they can be rather than sitting on the sidelines and being nervous about them.”
To contact the reporter on this story: Simran Jagdev in Toronto at sjagdev1@bloomberg.net
To contact the editors responsible for this story: Jacqueline Thorpe at jthorpe23@bloomberg.net, David Scanlan
©2019 Bloomberg L.P.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.